Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CpG methylation is an epigenetic modification that is important for embryonic development, imprinting, and X-chromosome inactivation. Additionally we are shipping DNMT3B Kits (16) and DNMT3B Proteins (9) and many more products for this protein.
Showing 10 out of 134 products:
Human Polyclonal DNMT3B Primary Antibody for IHC (p), WB - ABIN387884
Lu, Markowetz, Unwin, Leek, Airoldi, MacArthur, Lachmann, Rozov, Maayan, Boyer, Troyanskaya, Whetton, Lemischka: Systems-level dynamic analyses of fate change in murine embryonic stem cells. in Nature 2009
Show all 13 Pubmed References
Human Polyclonal DNMT3B Primary Antibody for ChIP, IHC - ABIN152675
Okano, Bell, Haber, Li: DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. in Cell 1999
Show all 6 Pubmed References
Human Polyclonal DNMT3B Primary Antibody for IF (p), IHC (p) - ABIN727623
Zhao, Hou, Chen, Shao, Zhu, Bu, Gu, Li, Zhang, Du, Fu, Kong, Luo, Long, Li, Deng, Zhao, Cen: Prenatal cocaine exposure impairs cognitive function of progeny via insulin growth factor II epigenetic regulation. in Neurobiology of disease 2015
Show all 2 Pubmed References
Human Monoclonal DNMT3B Primary Antibody for ChIP, WB - ABIN2668954
Castro, Breiling, Luetkenhaus, Ceteci, Hausmann, Kress, Lyko, Rudel, Rapp: MYC-induced epigenetic activation of GATA4 in lung adenocarcinoma. in Molecular cancer research : MCR 2013
Show all 2 Pubmed References
Mouse (Murine) Polyclonal DNMT3B Primary Antibody for WB - ABIN2668253
Ajj, Chesnel, Pinel, Plenat, Flament, Dumond: An alkylphenol mix promotes seminoma derived cell proliferation through an ERalpha36-mediated mechanism. in PLoS ONE 2013
Human Monoclonal DNMT3B Primary Antibody for WB - ABIN2668953
Felle, Joppien, Németh, Diermeier, Thalhammer, Dobner, Kremmer, Kappler, Längst: The USP7/Dnmt1 complex stimulates the DNA methylation activity of Dnmt1 and regulates the stability of UHRF1. in Nucleic acids research 2011
Among 18 genotypes analyzed, we were unable to record any significant differences in 5-methyl-2'-deoxycytidine levels, which suggested that age-related changes in global DNA methylation (show HELLS Antibodies) content are rather a function of time, and not a genetic component.
Developmental changes in expression of DNMT3B are indicative of a possible role in changes in methylation in cattle.
The expression levels of DNMT3a (show DNMT3A Antibodies) and DNMT3b were associated with several beef quality traits.
Data indicate a role for DNA methyltransferase 3B (DNMT3B) suggesting that it might substitute for the absent accessory protein DNMT3L (show TRDMT1 Antibodies) to recruit DNMT3A (show DNMT3A Antibodies) in somatic cells.
These results provided evidence that the DNMT3B -283T>C polymorphism might significantly contribute to the lung cancer risk in the Asian population, but not the gastric cancer risk in the Chinese population.
There was no significant difference in the distribution of DNMT3B -579 G>T genotypes between the cases and controls.
The epigenetic targets AURKB (show AURKB Antibodies), AURKC (show AURKC Antibodies) and DNMT3B, and the global DNA methylation (show HELLS Antibodies) profile are regulated during HIV-1 replication in CD4 (show CD4 Antibodies)+ T cells, and this regulation can be influenced by the activation state of the cell at the time of infection.
Data suggest that female patients carrying the rs2424932 or rs998382 variants of DNA methyltransferase 3b (DNMT3) were more likely to develop Parkinson's disease (PD) than female controls.
Our study expands the mutation spectrum in ICF syndrome and supports that DNMT3B and ZBTB24 (show ZBTB24 Antibodies) are the most common disease genes
Alternative splice variant of DNMT3B is associated with leukemia.
these results provided a plausible link between the observed reduction of miR (show MLXIP Antibodies)-26a and MEG3 (show FAM129B Antibodies) in HCCs (show HCCS Antibodies). Together, the present study added miR (show MLXIP Antibodies)-26a/DNMT3B/MEG3 (show FAM129B Antibodies) axis to the complex mechanisms of HCC (show FAM126A Antibodies) development.
Results show that DNMT1 (show DNMT1 Antibodies) mRNA levels were significantly higher in alveolar rhabdomyosarcoma and embryonal rhabdomyosarcoma tumors compared to normal skeletal muscle. Thse data indicate that altered expression of DNMT3B plays a key role in embryonal rhabdomyosarcoma development since its silencing is able to reverse cell cancer phenotype by rescuing myogenic program.
The present study shows that DNMT3B rs2424913 promotor polymorphism represents a genetic risk factor that may play an important role in understanding the pathogenesis of chronic immune thrombocytopenia.
The epiblast expressed epithelial markers, MUC1 (show MUC1 Antibodies) and E-CADHERIN (show CDH1 Antibodies), and the pluripotency markers, DNMT3B and CRIPTO (show TDGF1 Antibodies).
The aim of the present study is to investigate spatial and temporal expression levels and subcellular localizations of the DNMT1 (show DNMT1 Antibodies), DNMT3A (show DNMT3A Antibodies), and DNMT3B proteins in the mouse germinal vesicle (GV) and metaphase II (MII) oocytes, and early embryos from 1-cell to blastocyst stages.
Altogether, the authors demonstrate that Dnmt3a (show DNMT3A Antibodies) and Dnmt3b protect the epidermis from tumorigenesis and that squamous carcinomas are sensitive to inhibition of PPAR-gamma (show PPARG Antibodies).
a new paradigm of transcriptional regulation critical for cardiac development and maturation that is controlled by the interaction of REST, DNMT3B and non-CpG methylation.
Together, this study described the regulation of Chk2 (show CHEK2 Antibodies) expression through promoter methylation by Dnmt3b and also presented a novel role of Chk2 (show CHEK2 Antibodies) during neuronal differentiation, which is independent of its previously known function in DNA damage response.
in mouse embryonic stem cells, Dnmt3b-dependent intragenic DNA methylation protects the gene body from spurious RNA polymerase II entry and cryptic transcription initiation
three DNA methyltransferases, Dnmt1 (show DNMT1 Antibodies), Dnmt3a (show DNMT3A Antibodies), and Dnmt3b, have been identified. Dnmt3a (show DNMT3A Antibodies) and Dnmt3b are responsible for establishing DNA methylation (show HELLS Antibodies) patterns produced through their de novo-type DNA methylation (show HELLS Antibodies) activity in implantation stage embryos and during germ cell differentiation. Dnmt3-like (Dnmt3l (show TRDMT1 Antibodies)), which is a member of the Dnmt3 family but does not possess DNA methylation (show HELLS Antibodies)
While lens epithelial cell survival requires DNMT1 (show DNMT1 Antibodies), morphologically normal lenses develop in the absence of both DNMT3A (show DNMT3A Antibodies) and DNMT3B.
Mechanical stimulation regulates osteoblastic genes expression via direct regulation of Dnmt3b.
a miR (show MLXIP Antibodies)-125b-DNMT3b-p53 (show TP53 Antibodies) signal pathway may exist in the vascular smooth muscle cells proliferation induced by homocysteine.
miR (show MLXIP Antibodies)-29a mimic transfection lowered collagen 1alpha1, DNMT1 (show DNMT1 Antibodies), DNMT3b and SET1A (show SETD1A Antibodies) expression in hepatic stellate cells.
dnmt7 specifically methylates no tail gene in the genome
CpG methylation is an epigenetic modification that is important for embryonic development, imprinting, and X-chromosome inactivation. Studies in mice have demonstrated that DNA methylation is required for mammalian development. This gene encodes a DNA methyltransferase which is thought to function in de novo methylation, rather than maintenance methylation. The protein localizes primarily to the nucleus and its expression is developmentally regulated. Mutations in this gene cause the immunodeficiency-centromeric instability-facial anomalies (ICF) syndrome. Eight alternatively spliced transcript variants have been described. The full length sequences of variants 4 and 5 have not been determined.
DNA cytosine-5 methyltransferase 3 beta
, DNA (cytosine-5)-methyltransferase 3B
, DNA methyltransferase HsaIIIB
, DNA (cytosine-5-)-methyltransferase 3 beta
, DNA MTase HsaIIIB
, DNA methyltransferase 3B
, DNA (cytosine-5)-methyltransferase 3B-like
, DNA MTase MmuIIIB
, DNA methyltransferase MmuIIIB
, DNA (cytosine-5-)-methyltransferase 3 beta, like
, DNA (cytosine-5-)-methyltransferase 7
, LOW QUALITY PROTEIN: DNA (cytosine-5)-methyltransferase 3B